Blue Bell Private Wealth Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $624 | Hold |
19
| – | – | ﹤0.01% | 697 |
|
|
2025
Q1 | $588 | Hold |
19
| – | – | ﹤0.01% | 694 |
|
|
2024
Q4 | $719 | Hold |
19
| – | – | ﹤0.01% | 647 |
|
|
2024
Q3 | $833 | Hold |
19
| – | – | ﹤0.01% | 652 |
|
|
2024
Q2 | $773 | Hold |
19
| – | – | ﹤0.01% | 677 |
|
|
2024
Q1 | $842 | Hold |
19
| – | – | ﹤0.01% | 687 |
|
|
2023
Q4 | $855 | Hold |
19
| – | – | ﹤0.01% | 680 |
|
|
2023
Q3 | $753 | Hold |
19
| – | – | ﹤0.01% | 641 |
|
|
2023
Q2 | $897 | Hold |
19
| – | – | ﹤0.01% | 643 |
|
|
2023
Q1 | $912 | Hold |
19
| – | – | ﹤0.01% | 621 |
|
|
2022
Q4 | $936 | Sell |
19
-22
| -54% | -$1.08K | ﹤0.01% | 640 |
|
|
2022
Q3 | $2K | Hold |
41
| – | – | ﹤0.01% | 591 |
|
|
2022
Q2 | $2K | Sell |
41
-85
| -67% | -$4.15K | ﹤0.01% | 630 |
|
|
2022
Q1 | $8K | Hold |
126
| – | – | ﹤0.01% | 457 |
|
|
2021
Q4 | $10K | Buy |
+126
| New | +$10K | ﹤0.01% | 397 |
|